100s of titles, one news app for just $10 a month.
Latest Business news:
RIP Davos Man, long live globalization
Open markets aren’t what they used to be. A more complicated, more regional economic system is reshaping the global order.
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
"Activision Blizzard can't stop this.” Why Raven Software's union is just the beginning
Employees at Raven Software have formed the first major union in the video game industry, and it's a massive victory…
Chanel's private boutiques ensure rich clients won't mingle with the plebs
Only "top spenders" will be allowed to step foot in Chanel's new elite-only boutiques.
Meta asks to be spared tighter rules in Australia, saying iPhone’s tracking blocker is hurting business
Company tells consumer watchdog it is set to lose $10bn this year in wake of Apple iOS feature hampering ability…
Business investment expected to pick up
Economists expect figures will show business investment picked up further in the March quarter, providing a boost to growth in…
From analysis to good news, read the world’s best news in one place
Woolworths brings in more cameras amid suspected rise in shoplifting
Supermarket giant Woolworths has installed cameras above self-service checkouts at select stores amid fears about a rise in shoplifting.
Super co-contribution has cost $10 billion to help the wrong Australians – so let's scrap it
Concerned that many people won’t have enough retirement savings even with compulsory superannuation, since 2003 the Australian government has had…

23 Stocks Moving in Friday's Pre-Market Session

By Lisa Levin

Gainers

  • OTR Acquisition Corp. (NASDAQ:OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.
  • Calithera Biosciences, Inc. (NASDAQ:CALA) rose 46.3% to $0.2358 in pre-market trading. The company recently reported a net loss of $13.8 million for the three months ended March 31, 2022.
  • Affirm Holdings, Inc. (NASDAQ:AFRM) shares rose 31.2% to $23.66 in pre-market trading after the company reported upbeat results for its third quarter and raised its revenue forecast for the fiscal year. The company also announced a multi-year extension of its partnership in the U.S. with Shopify.
  • Molecular Partners AG (NASDAQ:MOLN) rose 28.2% to $7.79 in pre-market trading. Molecular Partners recently said its partner Novartis expects the FDA may require additional clinical data for the Emergency Use Application for ensovibep.
  • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) rose 22.5% to $0.1630 in pre-market trading after jumping over 70% on Thursday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
  • Robinhood Markets, Inc. (NASDAQ:HOOD) shares rose 22% to $10.46 in pre-market trading after a 13D filing showed Samuel Bankman-Fried, founder and CEO of FTX crypto exchange, disclosed a 7.6% stake in the company.
  • Landos Biopharma, Inc. (NASDAQ:LABP) rose 19% to $0.7959 in pre-market trading after the company said Q1 EPS results were higher year over year.
  • Duolingo, Inc. (NASDAQ:DUOL) rose 17.6% to $78.81 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results.
  • Molecular Data Inc. (NASDAQ:MKD) rose 14.6% to $0.1044 in pre-market trading after jumping around 17% on Thursday.
  • SciSparc Ltd. (NASDAQ:SPRC) rose 13.4% to $3.29 in pre-market trading after jumping 23% on Thursday.
  • KULR Technology Group, Inc. (NASDAQ:KULR) rose 13.1% to $1.38 in pre-market trading after dropping 4% on Thursday.
  • McEwen Mining Inc. (NYSE:MUX) rose 12.1% to $0.5167 in pre-market trading. McEwen Mining recently posted a Q1 loss of $0.04 per share.
  • Redwire Corporation (NYSE:RDW) rose 10.8% to $4.10 in pre-market trading following Q1 results.
  • Fangdd Network Group Ltd. (NASDAQ:DUO) rose 9.3% to $0.2352 in pre-market trading after gaining around 8% on Thursday.
  • The RealReal, Inc. (NASDAQ:REAL) rose 9.3% to $3.52 in pre-market trading after dipping around 6% on Thursday.

Don’t forget to check out our premarket coverage here .

Losers

  • LiqTech International, Inc. (NASDAQ:LIQT) shares fell 48.6% to $0.47 in pre-market trading after the company priced its public offering of common stock and pre-funded warrants.
  • FIGS, Inc. (NYSE:FIGS) shares fell 25.1% to $9.62 in pre-market trading after the company reported worse-than-expected Q1 adjusted EPS and sales results and cut FY22 sales guidance to below analyst estimates.
  • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares fell 14.4% to $0.19 in pre-market trading. Salarius Pharmaceuticals posted a Q1 loss of $0.13 per share.
  • Twitter, Inc. (NYSE:TWTR) fell 14.2% to $38.70 in pre-market trading. After running the hard mile to mobilize finances for his Twitter buy, Elon Musk said early Friday the deal is on hold.
  • Stealth BioTherapeutics Corp (NASDAQ:MITO) fell 9.5% to $0.2262 in pre-market trading. Stealth BioTherapeutics shares jumped around 32% on Thursday after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
  • Dakota Gold Corp. (NYSE:DC) fell 9.3% to $2.90 in pre-market trading after dipping 6% on Thursday.
  • Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 8.4% to $0.2250 in pre-market trading. Regulus Therapeutics posted a Q1 loss of $0.05 per share.
  • Sky Harbour Group Corporation (NYSE:SKYH) fell 6.7% to $8.05 in pre-market trading after reporting Q1 results.
What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.